Cowen analyst Yaron Werber initiates coverage on Spring Works Therapeutics (NASDAQ: SWTX) with a Outperform rating.The analyst comments "SpringWorks is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE